Perrigo Company plc (NYSE; TASE: PRGO) today announced results for the second quarter ended July 1, 2017.
Additional GAAP reported results: Reported net sales were lower in the Consumer Healthcare Americas ("CHCA") and Consumer Healthcare International ("CHCI") segments by 4% and 9%, respectively, due primarily to actions taken last year to sell non-profitable businesses. CHCA reported operating margin was 17.2%.
Additional GAAP reported results: Reported net sales were lower in the Consumer Healthcare Americas ("CHCA") and Consumer Healthcare International ("CHCI") segments by 4% and 9%, respectively, due primarily to actions taken last year to sell non-profitable businesses. CHCA reported operating margin was 17.2%.
